These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8254656)

  • 21. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.
    Ciatto C; Tissot AC; Tschopp M; Capitani G; Pecorari F; Plückthun A; Grütter MG
    J Mol Biol; 2001 Oct; 312(5):1059-71. PubMed ID: 11580250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
    Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
    Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
    Gao GF; Tormo J; Gerth UC; Wyer JR; McMichael AJ; Stuart DI; Bell JI; Jones EY; Jakobsen BK
    Nature; 1997 Jun; 387(6633):630-4. PubMed ID: 9177355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.
    Teng MK; Smolyar A; Tse AG; Liu JH; Liu J; Hussey RE; Nathenson SG; Chang HC; Reinherz EL; Wang JH
    Curr Biol; 1998 Mar; 8(7):409-12. PubMed ID: 9545202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding.
    Stryhn A; Pedersen LO; Romme T; Holm CB; Holm A; Buus S
    Eur J Immunol; 1996 Aug; 26(8):1911-8. PubMed ID: 8765039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains.
    Elliott T; Elvin J; Cerundolo V; Allen H; Townsend A
    Eur J Immunol; 1992 Aug; 22(8):2085-91. PubMed ID: 1639105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide interactions with G-protein coupled receptors.
    Marshall GR
    Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.
    Zarutskie JA; Sato AK; Rushe MM; Chan IC; Lomakin A; Benedek GB; Stern LJ
    Biochemistry; 1999 May; 38(18):5878-87. PubMed ID: 10231540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
    Yaneva R; Springer S; Zacharias M
    Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.
    Menssen R; Orth P; Ziegler A; Saenger W
    J Mol Biol; 1999 Jan; 285(2):645-53. PubMed ID: 9878435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
    Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
    Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.
    Madurga S; Belda I; Llorà X; Giralt E
    Protein Sci; 2005 Aug; 14(8):2069-79. PubMed ID: 16046628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8.
    Sekimata M; Tanabe M; Sarai A; Yamamoto J; Kariyone A; Nakauchi H; Egawa K; Takiguchi M
    J Immunol; 1993 May; 150(10):4416-26. PubMed ID: 8482843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.